Brain damage and motor cortex impairment in chronic obstructive pulmonary disease: Implication of nonrapid eye movement sleep desaturation

Sleep

Volumn 39, Issue 2, 2016, Pages 327-335

  Alexandre, Francois ^a,b   Heraud, Nelly ^b,c   Sanchez, Anthony M J ^d,e   Tremey, Emilie ^b,c   Oliver, Nicolas ^b   Guerin, Philippe ^c   Varray, Alain ^a  

^a UNIVERSITY OF MONTPELLIER   (France)

^b Clinique du Souffle la Vallonie Fontalvie   (France)

^c Fontalvie   (France)

^d University of Montpellier   (France)

^e University of Perpignan via Domitia   (France)

Author keywords

Central nervous system; Cerebral cortex; Electromyography; Muscle weakness; Voluntary activation

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROMYOGRAPHY; EXCITABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR CORTEX; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONREM SLEEP; OXYGEN DESATURATION; PREVALENCE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SLEEP TIME; BLOOD; BRAIN INJURY; COMPLICATION; INNERVATION; METABOLISM; MIDDLE AGED; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; SLEEP; VERY ELDERLY;

BIOLOGICAL MARKER; OXYGEN; PROTEIN S100B; S100B PROTEIN, HUMAN;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BRAIN INJURIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; MUSCLE CONTRACTION; MUSCLE STRENGTH; OXYGEN; POLYSOMNOGRAPHY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SLEEP;

EID: 84957061057     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.5438     Document Type: Article

References (56)

1. Orth M, Diekmann C, Suchan B, et al. Driving performance in patients with chronic obstructive pulmonary disease. J Physiol Pharmacol 2008;59:539-47.
2. Alexandre F, Heraud N, Oliver N, Varray A. Cortical implication in lower voluntary muscle force production in non-hypoxemic COPD patients. PloS Oone 2014;9:e100961.
3. Zheng GQ, Wang Y, Wang XT. Chronic hypoxia-hypercapnia influences cognitive function: A possible new model of cognitive dysfunction in chronic obstructive pulmonary disease. Med Hypotheses 2008;71:111-3.
4. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010;35:913-22.
5. Gupta PP, Sood S, Atreja A, Agarwal D. A comparison of cognitive functions in non-hypoxemic chronic obstructive pulmonary disease (COPD) patients and age-matched healthy volunteers using minimental state examination questionnaire and event-related potential, P300 analysis. Lung India 2013;30:5-11.
6. Liesker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med 2004;98:351-6.
7. Harris AD, Murphy K, Diaz CM, et al. Cerebral blood flow response to acute hypoxic hypoxia. NMR Biomed 2013;26:1844-52.
8. Shapiro W, Wasserman AJ, Baker JP, Patterson JL Jr. Cerebrovascular response to acute hypocapnic and eucapnic hypoxia in normal man. J Clin Invest 1970;49:2362-8.
9. Albayrak R, Fidan F, Unlu M, et al. Extracranial carotid Doppler ultrasound evaluation of cerebral blood flow volume in COPD patients. Respir Med 2006;100:1826-33.
10. Yildiz S, Kaya I, Cece H, et al. Impact of COPD exacerbation on cerebral blood flow. Clin Imaging 2012;36:185-90.
11. Vogiatzis I, Louvaris Z, Habazettl H, et al. Cerebral cortex oxygen delivery and exercise limitation in patients with COPD. Eur Respir J 2013;41:295-301.
12. Hajak G, Klingelhofer J, Schulz-Varszegi M, Sander D, Ruther E. Sleep apnea syndrome and cerebral hemodynamics. Chest 1996;110:670-9.
13. Balfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas. Am J Respir Crit Care Med 1994;150:1587-91.
14. Meyer JS, Ishikawa Y, Hata T, Karacan I. Cerebral blood flow in normal and abnormal sleep and dreaming. Brain Cogn 1987;6:266-94.
15. Meadows GE, O'Driscoll DM, Simonds AK, Morrell MJ, Corfield DR. Cerebral blood flow response to isocapnic hypoxia during slow-wave sleep and wakefulness. J Appl Physiol 2004;97:1343-8.
16. Corfield DR, Meadows GE. Control of cerebral blood flow during sleep and the effects of hypoxia. Adv Exp Med Biol 2006;588:65-73.
17. Lacasse Y, Series F, Vujovic-Zotovic N, et al. Evaluating nocturnal oxygen desaturation in COPD-revised. Respir Med 2011;105:1331-7.
18. Levi-Valensi P, Weitzenblum E, Rida Z, et al. Sleep-related oxygen desaturation and daytime pulmonary haemodynamics in COPD patients. Eur Respir J 1992;5:301-7.
19. Chaouat A, Weitzenblum E, Kessler R, et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J 1997;10:1730-5.
20. McSharry DG, Ryan S, Calverley P, Edwards JC, McNicholas WT. Sleep quality in chronic obstructive pulmonary disease. Respirology 2012;17:1119-24.
21. Lahousse L, van den Bouwhuijsen QJ, Loth DW, et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: The Rotterdam Study. Am J Respir Crit Care Med 2013;187:58-64.
22. Li J, Fei GH. The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res 2013;14:140.
23. Reeves RH, Yao J, Crowley MR, et al. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc Natl Acad Sci U S A 1994;91:5359-63.
24. Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 2003;21:97-108.
25. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62:1303-10.
26. Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997;34:546-50.
27. Bottiger BW, Mobes S, Glatzer R, et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001;103:2694-8.
28. Sen J, Belli A. S100B in neuropathologic states: The CRP of the brain? J Neurosci Res 2007;85:1373-80.
29. Pham N, Fazio V, Cucullo L, et al. Extracranial sources of S100B do not affect serum levels. PloS One 2010;5:e12691.
30. GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2014.Available from: http://www.goldcopd.org/.
31. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
32. Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012;8:597-619.
33. Park SY, Kim SM, Sung JJ, et al. Nocturnal hypoxia in ALS is related to cognitive dysfunction and can occur as clusters of desaturations. PloS One 2013;8:e75324.
34. van Gestel AJ, Clarenbach CF, Stowhas AC, et al. Prevalence and prediction of exercise-induced oxygen desaturation in patients with chronic obstructive pulmonary disease. Respi Int Rev Thorac Dis 2012;84:353-9.
35. Brooks D, Solway S, Gibbons WJ. ATS statement on six-minute walk test. Am J Respir Crit Care Med 2003;167:1287.
36. Temesi J, Gruet M, Rupp T, Verges S, Millet GY. Resting and active motor thresholds versus stimulus-response curves to determine transcranial magnetic stimulation intensity in quadriceps femoris. J Neuroeng Rehabil 2014;11:40.
37. Allen GM, Gandevia SC, McKenzie DK. Reliability of measurements of muscle strength and voluntary activation using twitch interpolation. Muscle Nerve 1995;18:593-600.
38. Sidhu SK, Bentley DJ, Carroll TJ. Cortical voluntary activation of the human knee extensors can be reliably estimated using transcranial magnetic stimulation. Muscle Nerve 2009;39:186-96.
39. Lee M, Gandevia SC, Carroll TJ. Cortical voluntary activation can be reliably measured in human wrist extensors using transcranial magnetic stimulation. Clin Neurophysiol 2008;119:1130-8.
40. Vivodtzev I, Flore P, Levy P, Wuyam B. Voluntary activation during knee extensions in severely deconditioned patients with chronic obstructive pulmonary disease: benefit of endurance training. Muscle Nerve 2008;37:27-35.
41. Weitzenblum E, Chaouat A. Sleep and chronic obstructive pulmonary disease. Sleep Med Rev 2004;8:281-94.
42. Becker HF, Piper AJ, Flynn WE, et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 1999;159:112-8.
43. Zanchet RC, Viegas CA. Nocturnal desaturation: predictors and the effect on sleep patterns in patients with chronic obstructive pulmonary disease and concomitant mild daytime hypoxemia. J Bras Pneumol 2006;32:207-12.
44. Koo KW, Sax DS, Snider GL. Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med 1975;58:663-70.
45. Papaiordanidou M, Guiraud D, Varray A. Kinetics of neuromuscular changes during low-frequency electrical stimulation. Muscle Nerve 2010;41:54-62.
46. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-85.
47. Fryer G, Pearce AJ. The effect of lumbosacral manipulation on corticospinal and spinal reflex excitability on asymptomatic participants. J Manipulative Physiol Ther 2012;35:86-93.
48. Mador MJ, Deniz O, Aggarwal A, Kufel TJ. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:102-8.
49. Seymour JM, Ward K, Raffique A, et al. Quadriceps and ankle dorsiflexor strength in chronic obstructive pulmonary disease. Muscle Nerve 2012;46:548-54.
50. Klass M, Baudry S, Duchateau J. Voluntary activation during maximal contraction with advancing age: A brief review. Eur J Appl Physiol 2007;100:543-51.
51. Herbert RD, Gandevia SC. Twitch interpolation in human muscles: mechanisms and implications for measurement of voluntary activation. J Neurophysiol 1999;82:2271-83.
52. Kooistra RD, de Ruiter CJ, de Haan A. Conventionally assessed voluntary activation does not represent relative voluntary torque production. Eur J Appl Physiol 2007;100:309-20.
53. Menon MK, Houchen L, Harrison S, Singh SJ, Morgan MD, Steiner MC. Ultrasound assessment of lower limb muscle mass in response to resistance training in COPD. Respir Res 2012;13:119.
54. Simoneau EM, Billot M, Martin A, Van Hoecke J. Antagonist mechanical contribution to resultant maximal torque at the ankle joint in young and older men. J Electromyogr Kinesiol 2009;19:e123-31.
55. Olopade C, Mensah E, Gupta R, et al. Noninvasive determination of brain tissue oxygenation during sleep in obstructive sleep apnea: A near-infrared spectroscopic approach. Sleep 2007;30:1747-55.
56. Matsuo A, Inoue Y, Namba K, Chiba H. Changes in cerebral hemoglobin indices in obstructive sleep apnea syndrome with nasal continuous positive airway pressure treatment. Sleep Breath 2011;15:487-92.